A prospective double-blind trial of a low molecular weight heparin once daily compared with a conventional low-dose heparin three times daily prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
Eriksson
B
B
Risberg
B
B
D004311:Double-Blind Method; D006493:Heparin / Q000008:administration & dosage*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006620:Hip Fractures / Q000150:complications / Q000601:surgery; D006801:Humans; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000517:prevention & control*; D013927:Thrombosis / Q000517:prevention & control*
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin